Back
Anavex Life Sciences Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
60
AVXL
Anavex Life Sciences
Last Price:
4.51
Seasonality Move:
23.76%
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
132.67
Seasonality Move:
8.89%
Buy
60
Anavex Life Sciences (AVXL)
is a Buy
Is Anavex Life Sciences a Buy, Sell or Hold?
- The current Anavex Life Sciences [AVXL] share price is $4.49. The Score for AVXL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- AVXL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $132.50. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AVXL Stock Price Chart
What is Anavex Life Sciences's stock price today?
-
The Anavex Life Sciences share price today is $4.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVXL is experiencing slight selling pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $132.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
AVXL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 63.62 | Buy |
| Chaikin Money Flow: | -69361 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.57 - 4.17) | Buy |
| Bollinger Bands (100): | (3.97 - 6.67) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.38 | Buy |
| Relative Strength Index (14 RSI): | 60.06 | Buy |
| Chaikin Money Flow: | -529387 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.82 - 133.16) | Buy |
| Bollinger Bands (100): | (111.37 - 133.05) | Buy |
AVXL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.99 | Buy |
| 20-day SMA: | 3.78 | Buy |
| 50-day SMA: | 4.38 | Buy |
| 200-day SMA: | 6.24 | Sell |
| 8-day EMA: | 4.06 | Buy |
| 20-day EMA: | 3.98 | Buy |
| 50-day EMA: | 4.38 | Buy |
| 200-day EMA: | 6.07 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 133.09 | Sell |
| 20-day SMA: | 128.08 | Buy |
| 50-day SMA: | 125.92 | Buy |
| 200-day SMA: | 113.27 | Buy |
| 8-day EMA: | 132.09 | Buy |
| 20-day EMA: | 129.71 | Buy |
| 50-day EMA: | 126.49 | Buy |
| 200-day EMA: | 117.96 | Buy |
Anavex Life Sciences Earnings Growth & AVXL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.09 per share, and a decrease next year of $0.25 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.01 per share.
Anavex Life Sciences Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||